Publications by authors named "Yoshimi Ide"

Claim this Profile
E
Examining the effectiveness of a deep learning-based computer-aided breast cancer detection system for breast ultrasound.
Tomoyuki Fujioka, Kazunori Kubota, Jen Feng Hsu, Ruey Feng Chang, Terumasa Sawada, Yoshimi Ide, Ukihide Tateishi

J Med Ultrason (2001)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of impact of the ALDH2 rs671 variant on breast cancer development in Japanese BRCA1/2-mutation carriers.
Tomoharu Mori, Yusuke Okamoto, Anfeng Mu, Yoshimi Ide, Akiyo Yoshimura

Cancer Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic performance of dedicated breast positron emission tomography.
Rikako Hashimoto, Sadako Akashi-Tanaka, Chie Watanabe, Hiroko Masuda, Kanae Taruno, Yoshimi Ide

Breast Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro synthesis of mucin-type O-glycans using saccharide primers comprising GalNAc-Ser and GalNAc-Thr residues.
Ryuma Sakura, Kaori Nagai, Yuka Yagi, Yoshihisa Takahashi, Yoshimi Ide

Carbohydr Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of high-risk hormone receptor-positive breast cancer patients was much higher in Japanese breast cancer patients with germline BRCA1/2 mutations than in sporadic breast cancer patients.
Yoshimi Ide, Lei Liu, Sakiko Miura, Mayuko Inuzuka, Sadako Akashi-Tanaka

Breast J· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCAness as a prognostic indicator in patients with early breast cancer.
Lei Liu, Yuki Matsunaga, Junji Tsurutani, Sadako Akashi-Tanaka, Hiroko Masuda, Yoshimi Ide

Sci Rep· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovative use of magnetic resonance imaging-guided focused ultrasound surgery for non-invasive breast cancer: a report of two cases.
Akiko Matsutani, Yoshimi Ide, Sakiko Miura, Masafumi Takimoto, Sadao Amano

Surg Case Rep· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of disease-causing genes in Japanese patients with -wildtype hereditary breast and ovarian cancer syndrome.
Tomoko Kaneyasu, Seiichi Mori, Hideko Yamauchi, Shozo Ohsumi, Shinji Ohno, Yoshimi Ide

NPJ Breast Cancer· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical impact of MRI screening for BRCA mutation carriers: the first report in Japan.
Wakana Murakami, Mitsuhiro Tozaki, Seigo Nakamura, Yoshimi Ide, Mayuko Inuzuka

Breast Cancer· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
Yan Liu, Yoshimi Ide, Mayuko Inuzuka, Sakiko Tazawa, Yoko Kanada

Mol Genet Genomic Med· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cystic apocrine ductal carcinoma in situ with increased EGFR expression, trisomy 7, and associated focal invasion.
Shogo Tajima, Michihiko Waki, Hatsuko Nasu, Yoshimi Ide

Med Mol Morphol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of Miller Fisher syndrome during preoperative chemotherapy for breast cancer.
Yumiko Taki, Yoshimi Ide, Shogo Tajima, Yuko Hosokawa, Ryoichi Matsunuma

Int J Clin Exp Med· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased level of phosphatidylcholine (16:0/20:4) in multiple myeloma cells compared to plasma cells: a single-cell MALDI-IMS approach.
Md Amir Hossen, Yasuyuki Nagata, Michihiko Waki, Yoshimi Ide, Shiro Takei

Anal Bioanal Chem· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palmitic acid, verified by lipid profiling using secondary ion mass spectrometry, demonstrates anti-multiple myeloma activity.
Yasuyuki Nagata, Itsuko Ishizaki, Michihiko Waki, Yoshimi Ide, Md Amir Hossen

Leuk Res· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell time-of-flight secondary ion mass spectrometry reveals that human breast cancer stem cells have significantly lower content of palmitoleic acid compared to their counterpart non-stem cancer cells.
Michihiko Waki, Yoshimi Ide, Itsuko Ishizaki, Yasuyuki Nagata, Noritaka Masaki, Takanori Hiraide

Biochimie· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human breast cancer tissues contain abundant phosphatidylcholine(36∶1) with high stearoyl-CoA desaturase-1 expression.
Yoshimi Ide, Michihiko Waki, Takahiro Hayasaka, Tomohisa Nishio, Yoshifumi Morita

PLoS One· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B virus reactivation in adjuvant chemotherapy for breast cancer.
Yoshimi Ide, Yoshinori Ito, Shunji Takahashi, Nahomi Tokudome, Kokoro Kobayashi

Breast Cancer· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accumulated phosphatidylcholine (16:0/16:1) in human colorectal cancer; possible involvement of LPCAT4.
Nobuya Kurabe, Takahiro Hayasaka, Mikako Ogawa, Noritaka Masaki, Yoshimi Ide

Cancer Sci· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological significance of invasive micropapillary carcinoma component in invasive breast carcinoma.
Yoshimi Ide, Rie Horii, Tomo Osako, Kaoru Ogura, Reiko Yoshida

Pathol Int· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-grade breast cancers include both highly sensitive and highly resistant subsets to cytotoxic chemotherapy.
Tomo Osako, Rie Horii, Masaaki Matsuura, Kaoru Domoto, Yoshimi Ide

J Cancer Res Clin Oncol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis